Advertisement
Screener

STERIS plc (STE) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period

2.8 / 5 stars · 68/120 Roast Me

STERIS plc Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period

New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.

  • STERIS plc share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 18.16K shares, a 75.50% decline year-over-year.
  • STERIS plc share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 28.07K shares, a 51.46% decline year-over-year.
  • STERIS plc share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 119.47K shares, a 5242.80% increase year-over-year.
  • STERIS plc share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 65.86K shares, a 38.35% decline year-over-year.
  • STERIS plc share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2026 was 287.51K shares, a 15.81% increase from fiscal 2025.
  • STERIS plc share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 248.26K shares, a 96.42% increase from fiscal 2024.
  • STERIS plc share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 126.39K shares, a 234.98% increase from fiscal 2023.
  • STERIS plc share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 37.73K shares, a 89.35% decline from fiscal 2022.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month
2026-06-3018.16K shares
10-Q · filed 2026-08-07
231.56K shares
derived: sum of 4 quarters · filed 2026-08-07
2026-03-3128.07K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-29
287.51K shares
10-K · filed 2026-05-29
2025-12-31119.47K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-06
317.27K shares
derived: sum of 4 quarters · filed 2026-02-06
2025-09-3065.86K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-06
200.04K shares
derived: sum of 4 quarters · filed 2025-11-06
2025-06-3074.12K shares
10-Q · filed 2025-08-07
241.00K shares
derived: sum of 4 quarters · filed 2025-08-07
2025-03-3157.82K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-29
248.26K shares
10-K · filed 2025-05-29
2024-12-312.24K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-07
262.95K shares
derived: sum of 4 quarters · filed 2025-02-07
2024-09-30106.83K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-07
273.00K shares
derived: sum of 4 quarters · filed 2024-11-07
2024-06-3081.38K shares
10-Q · filed 2024-08-08
176.43K shares
derived: sum of 4 quarters · filed 2024-08-08
2024-03-3172.51K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-29
126.39K shares
10-K · filed 2024-05-29
2023-12-3112.28K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-08
66.39K shares
derived: sum of 4 quarters · filed 2024-02-08
2023-09-3010.26K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-07
54.92K shares
derived: sum of 4 quarters · filed 2023-11-07
2023-06-3031.34K shares
10-Q · filed 2023-08-08
48.43K shares
derived: sum of 4 quarters · filed 2023-08-08
2023-03-3112.50K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2023-05-26
37.73K shares
10-K · filed 2023-05-26
2022-12-31820.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-08
75.14K shares
derived: sum of 4 quarters · filed 2023-02-08
2022-09-303.77K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-09
266.46K shares
derived: sum of 4 quarters · filed 2022-11-09
2022-06-3020.64K shares
10-Q · filed 2022-08-08
338.04K shares
derived: sum of 4 quarters · filed 2022-08-08
2022-03-3149.91K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-31
354.25K shares
10-K · filed 2022-05-31
2021-12-31192.14K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-09
319.16K shares
derived: sum of 4 quarters · filed 2022-02-09
2021-09-3075.35K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-11-08
219.91K shares
derived: sum of 4 quarters · filed 2021-11-08
2021-06-3036.85K shares
10-Q · filed 2021-08-09
340.33K shares
derived: sum of 4 quarters · filed 2021-08-09
2021-03-3114.82K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2021-05-28
399.91K shares
10-K · filed 2021-05-28
2020-12-3192.89K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-09
583.10K shares
derived: sum of 4 quarters · filed 2021-02-09
2020-09-30195.76K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-06
501.02K shares
derived: sum of 4 quarters · filed 2021-02-09
2020-06-3096.44K shares
10-Q · filed 2020-08-07
491.98K shares
derived: sum of 4 quarters · filed 2021-02-09
2020-03-31198.01K shares
derived: 8-K 12 month − 10-Q 9 month · filed 2021-02-09
613.09K shares
8-K · filed 2021-02-09
2019-12-3110.81K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-10
2019-09-30186.72K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-07
2019-06-30217.54K shares
10-Q · filed 2019-08-07
2019-03-31335.36K shares
10-K · filed 2019-05-30

Similar stocks

Stock NameCountryMarket CapPE Ratio
ZIMMER BIOMET HOLDINGS, INC. (ZBH)United States$17.103B20.66
ALIGN TECHNOLOGY INC (ALGN)United States$10.346B29.06
MSA Safety Inc (MSA)United States$7.023B21.47
ESTABLISHMENT LABS HOLDINGS INC. (ESTA)$1.954B-65.76
Cadre Holdings, Inc. (CDRE)United States$1.123B33.88
Enovis CORP (ENOV)United States$1.053B-1.18
Anteris Technologies Global Corp. (AVR)United States$0.746B
Sanara MedTech Inc. (SMTI)United States$0.323B-6.81
Inogen Inc (INGN)United States$0.139B-7.00
Conexeu Sciences Inc. (CNXU)United States$0.111B